To Assess the Impact of theERAS Consensus on Patients With Endoscopic Pituitary Tumor Surgery
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20-75
SponsorChang Gung Memorial Hospital
About this trial
The goal of this observational study is to evaluate the effectiveness and impact of Enhanced Recovery After Surgery (ERAS) on patients with pituitary gland tumors.
Eligibility criteria
Qualifiers
Clinical diagnosis of pituitary tumors
To sign a written informed consent form
Disqualifiers
Diagnosed with other malignant tumors
Severe infections, such as osteomyelitis, acute inflammation at the affected site, or open wounds at the treatment area
Pregnant women
Coagulation disorders or those taking anticoagulant medication
Trial design
Treatments tested in this trial
- Malnutrition Universal Screening Tool
- TIB Olfactory Test Device
- Apfel Score for Postoperative nausea and vomiting
- The American Society of Anesthesiologists (ASA) Physical Status Classification
- Short Form-36
- World Health Organization Quality of Life questionnaire (WHOQOL-BREF)
- BDI-II(Beck Depression Inventory-II)
- ERAS Patient Satisfaction Questionnaire(ERAS-PSQ)
- Quality of Recovery-40(QoR-40)
Treatment groups
70 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov